Daan C Velseboer1, Rob M A de Bie2, Luuk Wieske2, Jonathan R Evans2, Sarah L Mason2, Thomas Foltynie2, Ben Schmand2, Rob J de Haan2, Bart Post2, Roger A Barker2, Caroline H Williams-Gray2. 1. From the Department of Neurology (D.C.V., R.M.A.d.B., L.W.), Department of Medical Psychology (B.S.), and Clinical Research Unit (R.J.d.H.), Academic Medical Center, Amsterdam, the Netherlands; John Van Geest Centre for Brain Repair (J.R.E., S.L.M., R.A.B., C.H.W.-G.), Department of Clinical Neurosciences, University of Cambridge; Institute of Neurology (T.F.), University College London, UK; Department of Brain and Cognition (B.S.), University of Amsterdam; and Department of Neurology (B.P.), Radboud University Medical Center, Nijmegen, the Netherlands. d.c.velseboer@amc.uva.nl. 2. From the Department of Neurology (D.C.V., R.M.A.d.B., L.W.), Department of Medical Psychology (B.S.), and Clinical Research Unit (R.J.d.H.), Academic Medical Center, Amsterdam, the Netherlands; John Van Geest Centre for Brain Repair (J.R.E., S.L.M., R.A.B., C.H.W.-G.), Department of Clinical Neurosciences, University of Cambridge; Institute of Neurology (T.F.), University College London, UK; Department of Brain and Cognition (B.S.), University of Amsterdam; and Department of Neurology (B.P.), Radboud University Medical Center, Nijmegen, the Netherlands.
Abstract
OBJECTIVE: To develop a prognostic model to predict disease outcomes in individual patients with Parkinson disease (PD) and perform an external validation study in an independent cohort. METHODS: Model development was done in the Comorbidity and Aging in Rehabilitation Patients: The Influence on Activities (CARPA) cohort (Netherlands). External validation was performed using the Cambridgeshire Parkinson's Incidence from GP to Neurologist (CamPaIGN) cohort (UK). Both are longitudinal incident cohort studies that prospectively followed up patients with PD from the time of diagnosis. A composite outcome measure was made in which patients were classified as having an unfavorable prognosis when they had postural instability or dementia at the 5-year assessment (or at the last assessment before loss to follow-up), or had died before this time. The final model was derived with a backward selection strategy from candidate predictor variables that were measured at baseline. RESULTS: In the resulting model, higher patient age, higher Unified Parkinson's Disease Rating Scale motor examination axial score, and a lower animal fluency score were all associated with a higher probability of an unfavorable outcome. External validation confirmed good discriminative ability between favorable and unfavorable outcomes with an area under the receiver operating characteristic curve of 0.85 (95% confidence interval 0.77-0.93) and a well-calibrated model with a calibration slope of 1.13 and no significant lack of fit (Hosmer-Lemeshow test: p = 0.39). CONCLUSION: We constructed a model that allows individual patient prognostication at 5 years from diagnosis, using a small set of predictor variables that can easily be obtained by clinicians or research nurses.
OBJECTIVE: To develop a prognostic model to predict disease outcomes in individual patients with Parkinson disease (PD) and perform an external validation study in an independent cohort. METHODS: Model development was done in the Comorbidity and Aging in Rehabilitation Patients: The Influence on Activities (CARPA) cohort (Netherlands). External validation was performed using the Cambridgeshire Parkinson's Incidence from GP to Neurologist (CamPaIGN) cohort (UK). Both are longitudinal incident cohort studies that prospectively followed up patients with PD from the time of diagnosis. A composite outcome measure was made in which patients were classified as having an unfavorable prognosis when they had postural instability or dementia at the 5-year assessment (or at the last assessment before loss to follow-up), or had died before this time. The final model was derived with a backward selection strategy from candidate predictor variables that were measured at baseline. RESULTS: In the resulting model, higher patient age, higher Unified Parkinson's Disease Rating Scale motor examination axial score, and a lower animal fluency score were all associated with a higher probability of an unfavorable outcome. External validation confirmed good discriminative ability between favorable and unfavorable outcomes with an area under the receiver operating characteristic curve of 0.85 (95% confidence interval 0.77-0.93) and a well-calibrated model with a calibration slope of 1.13 and no significant lack of fit (Hosmer-Lemeshow test: p = 0.39). CONCLUSION: We constructed a model that allows individual patient prognostication at 5 years from diagnosis, using a small set of predictor variables that can easily be obtained by clinicians or research nurses.
Authors: Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl Journal: Mov Disord Date: 2004-09 Impact factor: 10.338
Authors: Bruno Dubois; David Burn; Christopher Goetz; Dag Aarsland; Richard G Brown; Gerald A Broe; Dennis Dickson; Charles Duyckaerts; Jefferey Cummings; Serge Gauthier; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre Journal: Mov Disord Date: 2007-12 Impact factor: 10.338
Authors: Caroline H Williams-Gray; Sarah L Mason; Jonathan R Evans; Thomas Foltynie; Carol Brayne; Trevor W Robbins; Roger A Barker Journal: J Neurol Neurosurg Psychiatry Date: 2013-06-18 Impact factor: 10.154
Authors: Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois Journal: Mov Disord Date: 2007-09-15 Impact factor: 10.338
Authors: Nirosen Vijiaratnam; Michael Lawton; Amanda J Heslegrave; Tong Guo; Manuela Tan; Edwin Jabbari; Raquel Real; John Woodside; Katherine Grosset; Viorica Chelban; Dilan Athauda; Christine Girges; Roger A Barker; John Hardy; Nicholas Wood; Henry Houlden; Nigel Williams; Yoav Ben-Shlomo; Henrik Zetterberg; Donald G Grosset; Thomas Foltynie; Huw R Morris Journal: J Neurol Neurosurg Psychiatry Date: 2022-05-16 Impact factor: 13.654
Authors: Bastiaan R Bloem; Jan H L Ypinga; Allison Willis; Colleen G Canning; Roger A Barker; Marten Munneke; Nienke M De Vries Journal: J Parkinsons Dis Date: 2018 Impact factor: 5.568
Authors: Jeanne C Latourelle; Michael T Beste; Tiffany C Hadzi; Robert E Miller; Jacob N Oppenheim; Matthew P Valko; Diane M Wuest; Bruce W Church; Iya G Khalil; Boris Hayete; Charles S Venuto Journal: Lancet Neurol Date: 2017-09-25 Impact factor: 44.182
Authors: Ruwani S Wijeyekoon; Deborah Kronenberg-Versteeg; Kirsten M Scott; Shaista Hayat; Joanne L Jones; Menna R Clatworthy; R Andres Floto; Roger A Barker; Caroline H Williams-Gray Journal: Front Neurol Date: 2018-10-16 Impact factor: 4.003